Blockchain Registration Transaction Record

Nutriband Secures $5.3M to Advance World's First Abuse-Deterrent Fentanyl Patch

Nutriband raises $5.3M to develop world's first abuse-deterrent fentanyl patch using AVERSA technology, targeting $80-200M in annual sales to combat opioid crisis.

This development matters significantly because it addresses the ongoing opioid crisis that has devastated communities worldwide. The AVERSA Fentanyl patch represents a crucial innovation in pain management by potentially reducing opioid abuse and diversion while still providing effective relief for legitimate patients. Given that fentanyl is among the most potent and dangerous opioids, an abuse-deterrent version could save countless lives by preventing misuse that often leads to overdose deaths. For healthcare providers, this technology offers a safer alternative for managing severe chronic pain, while for society, it represents progress in balancing pain treatment needs with public health safety concerns.